Naveed Shams
Overview
Explore the profile of Naveed Shams including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
970
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Rosenfeld P, Heier J, Hantsbarger G, Shams N
Ophthalmology
. 2006 Apr;
113(4):623.e1.
PMID: 16581423
Purpose: To investigate whether multiple intravitreal doses of up to 2 mg of an antigen-binding fragment known as ranibizumab, derived from a humanized anti-vascular endothelial growth factor antibody, can be...
12.
Heier J, Antoszyk A, Pavan P, Leff S, Rosenfeld P, Ciulla T, et al.
Ophthalmology
. 2006 Feb;
113(4):633.e1-4.
PMID: 16483659
Objective: To assess safety of repeated intravitreal injections of ranibizumab in treating neovascular age-related macular degeneration (AMD), and to assess changes in visual acuity (VA) and AMD lesion characteristics. Design:...
13.
Rosenfeld P, Schwartz S, Blumenkranz M, Miller J, Haller J, Reimann J, et al.
Ophthalmology
. 2005 May;
112(6):1048-53.
PMID: 15885778
Purpose: To investigate the maximum tolerated dose of ranibizumab administered as a single intravitreal injection. Design: Open-label, 5-center, uncontrolled, prospective, dose-ranging, interventional case series. Participants: Twenty-seven patients with subfoveal choroidal...
14.
Gunawardena K, Crame N, Mertz B, Shams N
Ophthalmologica
. 2003 Feb;
217(2):129-36.
PMID: 12592052
Purpose: To assess the safety of unoprostone isopropyl 0.15% ophthalmic solution (UIOS) in patients with mild to moderate asthma. Methods: Randomized, double-masked, two-period crossover, placebo-controlled study comparing unoprostone 0.15% with...
15.
Stewart W, Stewart J, Crockett S, Kubilus C, Brown A, Shams N
Acta Ophthalmol Scand
. 2002 Jun;
80(3):272-6.
PMID: 12059865
Purpose: To compare the cardiovascular effects of unoprostone 0.15%, timolol 0.5% and placebo in healthy adults during exercise using a treadmill test. Methods: Thirty subjects aged 18-37 years (mean age...
16.
Nordmann J, Mertz B, Yannoulis N, Schwenninger C, Kapik B, Shams N
Am J Ophthalmol
. 2002 Jan;
133(1):1-10.
PMID: 11755834
Purpose: A long-term comparison of the ocular hypotensive efficacy and safety of unoprostone isopropyl 0.15% twice daily with that of timolol maleate 0.5% twice daily and betaxolol HCl 0.5% twice...